Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-28 · accession 0001127602-24-023145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-29 | 2024-08-28 | TMO | Britt Lisa P. | SVP, Chief HR Off | F - Tax | $613.14 | -212.74 | 13.4K | -2% | -$130.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | F | D | 81.23 | $613.14 | 13,465.09 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-28 | F | D | 58.50 | $613.14 | 13,333.58 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-28 | F | D | 73.01 | $613.14 | 13,392.08 | D | — | — |